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ABSTRACT
Objectives: The Monitor Practice Program demonstrated that regular
monitoring and noninvasive management of dental caries is effective in
reducing the incremental DMFT (decayed, missing, and ﬁlled teeth) in
patients, within the construct of a 3-year randomized clinical trial. This
analysis evaluates the long-term cost-effectiveness of the preventive
approach underpinning the Caries Management System, used in the
general practice setting and modeled to the Australian population.
Methods: An individual patient-simulation Markov model was developed
to compare the long-term costs and outcomes of the Caries Management
System versus standard dental care in a hypothetical sample representative
of the Australian population. Eight Markov submodels were developed,
representing eight molar teeth (excluding wisdom teeth), each consisting of
11 health states simulating the incidence and progression of dental caries,
and future interventions such as ﬁllings and crowns. Transition probabili-
ties and costs assigned to health states were based on claims data from the
second largest private health insurer in Australia. The economic evaluation
was performed from the Australian private dental practitioner perspective.
The incremental cost per DMFT avoided was calculated at three time
points: 2 years, 3 years, and lifetime. Univariate sensitivity analysis was
conducted to test the robustness of the results.
Results: The incremental cost per DMFT avoided at 2 years, 3 years,
and lifetime was estimated to be $1287.07, $1148.91, and $1795.06,
respectively.
Conclusion: The analysis suggests that the Caries Management System is
most cost-effective in patients with a high risk of dental caries.
Keywords: cost-effectiveness, dental caries, economic analysis, prevention.
Introduction
The concept and practice of evidence-based care is well accepted,
and within the medical profession has become standard practice.
Historically, the dental profession has been slower to fully adopt
the practice of evidence-based care [1,2]; however, in the past
decade, the dental profession has experienced a period of intense
interest in this concept. The American Dental Association in
particular has relied on credible scientiﬁc evidence in setting
dental policy, and in communication with dentists and the
general public [3].
The prevention of caries has been, and still is, a major goal for
the dental profession. Although several groups have performed
research designed to optimize the prevention of dental caries
[4–6], there are still evident disparities between the research
evidence into effective diagnosis and preventive interventions and
clinical practice [7]. Interest in how best to promote the uptake of
research ﬁndings has been fuelled by these evident disparities.
A systematic literature review identiﬁed 17 cost-effectiveness
analyses of preventive dental programs published since 1980
[8–24]. Despite the growing number of economic analyses of
preventive dental programs, it is unclear whether this growing
literature has impacted either public policy or the implementation
of evidence-based dentistry. A key criticism to date has been the
lack of generalizability as the vast majority of cost-effectiveness
research continues to be undertaken within public institutions;
whereas, 83% of dental services in Australia are provided within
private practice [25]. The majority of economic analyses of pre-
ventive dental programs report cost-effectiveness in terms of
incremental cost per DMFS (decayed, missing, and ﬁlled surfaces)
or DMFT (decayed, missing, and ﬁlled teeth) avoided [11–13,15–
19], given that the composite measures, DMFS and DMFT are the
standard measures of dental caries [26]. However, few modeled
economic analyses of preventive dental programs extrapolate the
costs and outcomes beyond the duration of the clinical trial on
which the efﬁcacy results are based.
The structured preventive program under review, the Caries
Management System (CMS), involves a noninvasive strategy
designed to arrest and remineralize noncavitated lesions. Both
dental caries risk and dental caries treatment are managed
according to a set of protocols which include the following:
1. A case history and review of exposure to potential caries
risk factors such as:
• sucrose intake (including a 24-h diet assessment),
• ﬂuoride use and history of ﬂuoride exposure
• assessment of dental plaque control including oral
hygiene instruction and characterization of dental
plaque distribution
2. Clinical examination including assessment of tooth
morphology—smooth surfaces and ﬁssures are dried and
explored with sharp eyes and a blunt probe to reveal incipi-
ent lesions and enamel breaks. These are recorded on stan-
dard dental charts. Unless frank cavitation is evident, the
diagnosis of dentine caries is via a radiographic bitewing
survey.
3. Bitewing radiographic survey—radiolucencies are scored
according to a ﬁve-category system proposed by Mejare
et al. [27]. These results are entered on a form that allows
for multiple dated entries and serial review of radiographic
change.
4. Assessment of the patient’s caries risk status—following the
clinical examination and bitewing survey, the caries risk
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status of the patient is determined pragmatically. Risk of
caries, according to the CMS, is determined at the ﬁrst visit
solely according to the clinical presentation of the dentition
and at later follow-up appointments according to the inci-
dence rate of new lesions.
5. The status of each lesion—for lesions that do not extend
beyond the outer third of dentine, therapy entails profes-
sional 3-monthly ﬂuoride varnish applications in addition
to twice-daily toothbrushing with ﬂuoride toothpaste.
Deeper lesions are restored. The goal of this intensive inter-
vention is to reduce caries risk status which is assessed on
the basis of lesion behavior and rate of new lesion incidence
as determined via clinical inspection and bitewings at six
monthly intervals. More detailed review of the CMS has
been described by Evans et al. [28].
The effectiveness of the CMS has been assessed within the
context of a cluster randomized, controlled clinical trial in the
Australian private practice setting (The Monitor Practice
Program) [29]. The design of that clinical trial has been reported
in detail elsewhere [30]. In all, 902 patients were recruited within
22 dental practices (12 intervention and 10 control) between
May 2005 and February 2006 in an equal distribution of ﬂuo-
ridated and nonﬂuoridated localities in New South Wales and the
Australian Capital Territory. Sixteen male and six female dentists
were recruited with a median practice experience of 21 years
(range 10–51 years). The baseline characteristics of the trial
participants and efﬁcacy results are presented in Table 1 and
Table 2, respectively.
In the clinical trial, standard care was deﬁned as the usual
care provided to patients of a given practice, and should be
distinguished from standardization of technique or standard of
care. The standard care provided by the dentists involved in the
trial was categorized following a time-in-motion study at each
participating practice. A total of 426 dental procedures were
observed over a period of 5 months in the 22 recruited practices
by one researcher (BC). In all, 194 procedures in the control and
232 procedures in the intervention practices were observed. The
service delivery pattern of intervention and control practices was
not statistically signiﬁcant overall [30].
The results suggest that, at both two and three years, the
CMS signiﬁcantly reduces the incremental number of decayed,
missing, and ﬁlled teeth (DMFT score) in the study group, who
received preventive dental care (29 and Table 2). Efﬁcacy was
independent of age, gender, medical concerns, ﬂuoride history, or
previous history of dental caries.
The aims of the present article are 1) assess the cost-
effectiveness of the CMS based on the incidence of dental caries
and incremental efﬁcacy data taken directly from the clinical
trial; 2) to broaden currently available research on the cost-
effectiveness of preventive dental programs by describing in
detail a decision analytic model constructed to assess the cost-
effectiveness of the CMS clinical trial at two and three years after
adjusting the baseline incidence of caries to that of the Australian
population; 3) to present the results of modeling the results of the
CMS to an Australian population over a longer time horizon;
and 4) to extrapolate the costs and beneﬁts beyond the duration
of the trial on which efﬁcacy results were based, rarely seen in the
published literature.
Methods
The decision analytic model was constructed using Data 4.0
(TreeAge Software, Williamstown, MA).
Model Description
A patient-level simulation decision analytic model has been con-
structed to assess the long-term cost-effectiveness of the CMS
compared with standard dental care after adjusting the baseline
Table 1 Baseline characteristics of randomized patients
Characteristic
Control
standard care
Intervention Caries
Management System
Number of patients 450 452
Age (years)
Mean 45.8 43.9
SD 19.9 19.5
Minimum 5 6
Median 48 45
Maximum 89 88 P = 0.14
Gender
Female 210 (47%) 277 (61%)
Male 240 (53%) 175 (39%) P < 0.001
Risk status (baseline)
Low 299 (67%) 290 (64%)
Medium 33 (7%) 48 (11%)
High 118 (26%) 114 (25%) P = 0.23
Decayed, missing, and
ﬁlled surfaces (baseline)
Mean 24.6 24.3
SD 25.6 24.4
Minimum 0 0
Median 14 17
Maximum 124 112 P = 0.83
P-values are for comparisons between the treatment groups. Independent t-tests and analysis
of variance were used for continuous variables and the Fisher’s exact test for categorical
variables.
SD, standard deviation.
Table 2 Caries Management System RCT efﬁcacy results at two and
three years
Standard
care
Caries
Management
System P-value
Number of patients
randomized
450 452
Baseline Mean (SD) Mean (SD)
Decayed 2.6 (2.6) 2.9 (2.5) 0.2
Missing 1.4 (1.8) 1.4 (1.6) 0.9
Filled 4.3 (5.2) 4.3 (4.7) 0.8
DMFT 8.4 (8.6) 8.5 (8.2) 0.8
2-year increment
Decayed 0.7 (1.3) 0.4 (0.1) <0.001*
Missing 0.1 (0.5) 0.1 (0.4) 0.3
Filled 1.3 (1.7) 0.8 (1.4) <0.001*
DMFT 2.1 (2.8) 1.3 (2.1) <0.001*
2-year endpoint
Decayed 3.3 (3.2) 3.3 (2.7) 0.9
Missing 1.6 (1.9) 1.5 (1.6) 0.7
Filled 5.6 (6.1) 5.0 (5.3) 0.1
DMFT 10.5 (10.2) 9.8 (8.9) 0.3
3-year increment
Decayed 1.1 (1.6) 0.76 (1.2) 0.002*
Missing 0.3 (0.6) 0.2 (0.5) 0.1
Filled 2.8 (2.9) 2.2 (2.3) <0.001*
DMFT 4.2 (4.5) 3.3 (3.3) <0.001*
3-year endpoint
Decayed 3.7 (3.7) 3.6 (3.2) 0.8
Missing 1.8 (2.1) 1.7 (1.8) 0.6
Filled 7.2 (7.6) 6.5 (6.6) 0.1
DMFT 12.6 (12.3) 11.8 (10.8) 0.2
*Signiﬁcant at 0.05.
P-values are for comparisons between the treatment groups. Independent t-tests and analysis
of variance were used for continuous variables and the Fisher’s exact test for categorical
variables.
DMFT, decayed, missing, and ﬁlled teeth; SD, standard deviation.
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incidence of caries to that of the Australian population at three
time points; two years, three years and over a patient’s lifetime.
The model assesses the cost-effectiveness of the CMS in a
modeled cohort representative of the Australian population. The
equation used to calculate the incremental cost-effectiveness ratio
is as follows:
Incremental cost per DMFT avoided
Cost of CMS Cost of SC
DM
=
−
FT increment for CMS DMFT increment for SC−
(1)
Although the majority of modeled economic evaluations use
cohort models, there is an increase in use of patient-level simu-
lation models (also known as micro-simulation) [31]. Simula-
tions in the model occur at the patient level (randomly sampled
from a cohort of 10,000 patients with an age distribution similar
to that of the Australian population based on data from the
Australian Bureau of Statistics). Caries incidence, progression,
and resulting dental treatment, is based on eight independent
Markov submodels representing the impact of the CMS on the
eight molar teeth separately (Federation Dentaire International
(FDI) numbers 16, 17, 26, 27, 36, 37, 46 and 47). This allows
more sensitivity than a model constructed at the patient level as
it allows for the possibility that a patient may have experienced
tooth decay and/or dental intervention on several teeth during
his/her lifetime. The model simulates the natural history of dental
caries and associated dental intervention on each of the eight
molars over the sampled patient’s lifetime, for both the standard
care arm and the CMS.
Each independent Markov submodel has the following eleven
health states; No disease, Enamel caries, Dentine caries, Filling,
Repeat ﬁlling, Root canal, Crown, Extraction, Bridge, Implant
and Death (an absorbing health state). In each cycle (6 months),
patients can either remain in the health state they are in, or move
to another health state as depicted by the arrows in Figure 1. The
authors acknowledge that, in reality, patients can move from one
state to another state (i.e., patients can move directly from
dentine decay to extraction). However, given the extensive data
requirements needed to populate a model that allows all possible
transitions, the authors have identiﬁed the key transitions (as
shown in Fig. 1) and have modelled the impact of the CMS on
these transitions. Although not shown in Figure 1, patients can
move into the Death health state from any of the other health
states.
As reported in Curtis et al. [29], the clinical trial measured
efﬁcacy in terms of incremental Decayed, Missing, and Filled
Surfaces (DMFS). Because the economic model is stratiﬁed into
eight molars, the analysis assesses the cost-effectiveness in terms
of cost per DMFT avoided. The DMFS score has been converted
to DMFT and Table 2 reports the two and three year efﬁcacy
results of the trial in terms of incremental DMFT. For each
hypothetical patient that progresses through the model, the
DMFT is assessed at three time points: 2 years, 3 years, and end
of life. As patients simulate through the Markov process, their
DMFT increment increases by one each time they enter any of the
following four health states: enamel caries, ﬁlling, repeat ﬁlling
and tooth extraction. Transitioning into the other health states
does not impact a patient’s DMFT score. The eight Markov
submodels run independently. Therefore if a patient receives a
ﬁlling on one tooth and a ﬁlling on another tooth, the patient’s
DMFT increment will increase by two.
Starting Distribution among Markov States
The age distribution of the 10,000 patients entering the model is
based on population data from the Australian Bureau of Statis-
tics [32]. Although there are 11 health states in each Markov
submodel, when patients ﬁrst enter the Markov process, it is
assumed that they enter in one of 6 health states; No decay,
enamel caries, dentine caries, ﬁlling, extraction or implant. Data
from the Australian Institute of Health and Welfare (AIHW) [33]
has been used to determine the distribution of patients among
these six states in each of the eight Markov submodels (Table 3).
Although the AIHW data are available to inform the probability
of entering the Markov model with dental caries, no information
was available on the split between enamel and dentine caries.
Arrow [34] reports the incidence of enamel and dentine caries in
157 school children in Western Australia over a 5-year period. In
that article, the incidence of enamel caries was 117 lesions per
100-tooth surface years while the incidence of dentine caries was
13.8 lesions per 100 tooth surface years. Thus the proportion of
patients with decay is divided between the two health states
(enamel decay and dentine decay) at a ratio of 8.5:1. The authors
acknowledge that ratio of enamel to dentine decay will be
increased in certain age groups, because until 12–24 months post
eruption the enamel surface is not fully matured. This more
porous enamel surface is likely to result in a higher rate of
progression to dentine decay. However, in the model it is assumed
that the ratio of 8.5:1 is applicable for all age groups.
Transition Probabilities
The six monthly probability of developing enamel caries was
taken directly from the 2-year results of the control arm in the
clinical trial (0.154 probability of developing enamel caries)
while the relationship between enamel and dentine caries has
been estimated from Arrow [34], resulting in 0.084 probability
of enamel caries progressing to dentine caries in any 6-month
Markov cycle. The 6-month probability of developing caries
assumed in the model is similar to the rate of caries assumed for
low-risk patients in Bader et al. [35]. Sensitivity analyses deter-
mine the impact of increasing the probability of developing
dental caries to be comparable with the medium- and high-risk
patients in Bader et al. [35]. Consistent with other economic
analyses of preventive dental programs [21,22]) and AIHW
dental statistics [36], the model assumes a constant relationship
between the incidence of dental caries and age. However, given
that permanent molar teeth have not erupted in young children,
the model assumes that the probability of dental caries is zero in
children under the age of 5 for tooth ID numbers 16, 26, 36, and
46 and zero under the age of 10 for tooth ID numbers 17, 27, 37,
and 47.
The six-month probability of progressing from enamel and
dentine caries to a ﬁlling was taken directly from the two-year
results of the control arm in the clinical trial. The six-month
probability of progressing from enamel caries to a ﬁlling was
0.199 for the control group for a patient with mean age 45. The
six-monthly probability of progressing from dentine caries to a
ﬁlling was 0.149. Consistent with other economic analyses of
preventive programs [21], the model assumes a linear relation-
ship between the incidence of ﬁllings and age (Table 4).
Transition probabilities between future dental interventions
(e.g., ﬁlling to root canal) were based on claims data from the
second largest private health insurer in Australia, Medical Beneﬁts
Fund (MBF). In 2007, 1.5 million persons had dental cover with
MBF. Utilization and cost (charge was used as a proxy) data were
based on all dental claims received and paid by MBF for services
incurred in 2007. These data were reported by the Australian
Dental Association (ADA) service item codes, routinely collected
by MBF. Four years of dental claims data were analyzed to derive
the transition probabilities between dental treatments (e.g.,
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transition from ﬁlling to root canal). This analysis was based on
members who had experienced at least two events of interest while
a member with the fund. The transition probabilities between
events was assumed to be constant with age i.e., the probabilities
of a repeat ﬁlling is dependant on occurrence of the ﬁrst ﬁlling and
not the patient’s age. For each paired event (e.g., ﬁlling to repeat
ﬁlling), the 6-month transition probability between the two events
was estimated based on the risk of the second event occurring and
the duration of time since the ﬁrst event occurred (Table 5).
Data from the Australian Bureau of Statistics have been used
to populate the model with respect to age-speciﬁc death rates
[37].
Comparative Effectiveness of the CMS
Table 2 reports the effectiveness of the clinical trial in terms of
DMFT increment at 2 and 3 years. The 2-year results from the
randomized controlled trial (RCT) have been used to model the
incremental effectiveness of the CMS and the 3-year results have
been used to validate the results generated at year 3 in the model.
The composite measure of DMFT was divided into individual
components in order to ascertain whether the number of decayed
(D), missing (M), or ﬁlled (F) teeth was a major contributor to
any differences between the groups. As shown in Table 2, imple-
mentation of the CMS within the clinical trial resulted in a
statistically signiﬁcant reduction in the incidence of decay, the
number of ﬁrst-time ﬁllings from enamel caries, and the number
of repeat ﬁllings over the 2-year period. When compared with the
control arm, the CMS resulted in a 40.3% reduction in the
incidence of decay (represented by D on Fig. 1), a 46.3% reduc-
tion in the number of ﬁrst-time ﬁllings from enamel caries (rep-
resented by F on Fig. 1), and a 54.2% reduction in the number of
repeat ﬁllings (represented by RF on Fig. 1) at 2 years. However,
the number of extractions was not signiﬁcantly reduced. Thus,
the analysis assumes that the rate of extraction is the same
between the two groups (represented by M on Fig. 1).
One of the main areas of uncertainty in the model relates to the
assumed duration of the incremental beneﬁt of the CMS over
standard care. The long-term impact of other preventive dental
programs has been used to inform this assumption. The effective-
ness of the preventive program assessed by Axelsson [38] was
maintained for 30 years. In patients who remained in the program,
the mean number of decayed surfaces was between 1.7 and 2.1
after 30 years, representing nearly complete effectiveness at pre-
venting caries and tooth loss [38]. These long-term results are
testament to what can be achieved if adherence to the program’s
monitoring protocol is high. However, the Axelsson study was
conducted in one dental practice only, making it easier to establish
and maintain adherence to the monitoring protocol. This raises
the question as to the generalizability and external validity of these
ﬁndings. An example of a preventive program that by its nature
creates a high level of adherence (and hence, the beneﬁt of the
program has been maintained over time) is that of water ﬂuori-
dation. The DMFT reductions of 50–60% observed in the 1950s
when ﬂuoridation programs were ﬁrst implemented have been
sustained until today [39]. However, results from other preventive
programs, such as sealant application without follow-up do not
demonstrate similar long-term efﬁcacy because upon sealant loss,
nonprotected susceptible surfaces soon decayed [40].
Within the clinical trial, the CMS was not completely effective
at preventing caries (i.e., the change from baseline in DMFT score
for the CMS group was greater than zero), so, for the purposes of
the modeling analysis, we assumed adherence to the CMS proto-
col to be less than perfect. However, the 2- and 3-year results of the
trial suggest that the incremental beneﬁt of the CMS compared
with standard dental care is maintained over that 3-year period
despite less than complete adherence to the monitoring protocol
(Table 2). This suggests that the level of (less than perfect) adher-
ence does appear to be maintained over the duration of the study.
Assuming that this level of adherence is maintained in the longer
term, it is reasonable to assume that the increment beneﬁt of the
CMS over standard care would be maintained in longer term.
Thus, the model assumes that the incremental beneﬁt of the CMS
observed in the trial is maintained for as long as the costs associ-
ated with the CMS protocol are incurred. A sensitivity analysis
determines the impact of varying this assumption.
Ongoing Costs Associated with Monitoring
Dental Caries
The schedule for monitoring caries activity in the CMS arm of
the model is derived from Evans et al. (2008) [28] and is shown
Table 3 Starting distribution of the population among the health states in each of the eight submodels
Age (years) No decay Enamel decay Dentine decay Filled Missing Implants
0–4 1 0 0 0 0 0
5 0.9636 0.024426 0.002874 0.0091 0 0
6 0.9804 0.0136 0.0016 0.0022 0.0022 0
7 0.9675 0.019774 0.002326 0.0081 0.0023 0
8 0.9616 0.020758 0.002442 0.0125 0.0027 0
9 0.9588 0.019774 0.002326 0.0176 0.0015 0
10 0.9593 0.017089 0.002011 0.0185 0.0031 0
11 0.9634 0.016553 0.001947 0.0171 0.001 0
12 0.9577 0.017805 0.002095 0.0207 0.0017 0
13 0.9483 0.020758 0.002442 0.0266 0.0019 0
14 0.9369 0.024068 0.002832 0.0336 0.0026 0
15–34 0.826875 0.025164 0.002961 0.035625 0.109375 0
35–54 0.635 0.025164 0.002961 0.1525 0.165625 0.01875
55–74 0.33375 0.016776 0.001974 0.21625 0.31875 0.1125
75 0.131875 0.01398 0.001645 0.19 0.440625 0.221875
Table 4 Six-monthly transition probabilities by age
Age
Enamel decay
to ﬁlling
Dentine decay
to ﬁlling
0 0.004337 0.003261
1 0.008673 0.006521
2 0.01301 0.009782
3 0.017347 0.013042
45 0.199485 0.149984
100 0.438 0.329312
In any given Markov cycle, a 45-year old patient in the Enamel decay health state will progress
to the Filling health state. This does not equate to a 0.199 probability that a 45-year old
patient will receive a ﬁlling within 6 months of the onset of enamel decay.
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in Table 6, resulting in a cost of $275.03 per visit. Units costs
included in this analysis are based on average charge data for
these services on dental claims paid by MBF for services incurred
in 2007. Thus, the unit cost is the charge by the dental practi-
tioner for the service, part or all of which may be reimbursed
directly to the dental practitioner by the health insurer (MBF)
where the patient has the appropriate level of private health
insurance cover. The remainder will be borne by the patient as a
member out of pocket expense.
Although the protocol for the CMS suggests more frequent
visits than currently performed in standard practice, the 2-year
[29] and 3-year results of the clinical trial suggest that the mean
number of visits was similar between groups (Table 2). In the
2-year results of the CMS clinical trial, the mean number of visits
was 0.82 per 6-month period [29]. Thus, the 6-monthly cost of
monitoring caries activity in the CMS arm was estimated to be
$226.88 per patient. In the model, the cost of monitoring caries
activity in the CMS arm is assumed to be the same as the
standard care arm after 20 years (40 6-monthly cycles). In the
standard care arm, it was assumed that patients receive one
plaque assessment and ﬂuoride application per visit, and one
double bitewing radiographic survey per year (Table 6). The
six-monthly cost of monitoring caries activity in the standard
care arm was estimated to be $106.00 per patient.
One-Off Costs Associated with Operative
Dental Interventions
MBF claims data from 2007 was also used to determine the
average unit cost of different dental interventions (such as ﬁllings,
root canals, etc.). The average unit cost of each treatment was
estimated as a weighted average of the charge for each ADA code
and the number of events of that ADA code that occurred
(Table 7).
Both costs and outcomes accrued after year 1, have been
discounted at 5%, and all costs are presented in Australian
dollars (AUD$ 2007, AUD$1 = USD$0.80). The perspective of
this analysis is from the private dental practitioner view, and as
such, no indirect or societal costs have been incorporated in the
model at this time.
Cost-Effectiveness Results
The trial-based economic evaluation assessed the cost-
effectiveness of the CMS versus standard care based on the
incidence of dental caries and incremental efﬁcacy data taken
directly from the clinical trial. At 2 years, the incremental cost
per DMFT avoided is estimated to be $539.17, increasing to
$694.47 at 3 years (Table 8).
The modeled analysis estimates the cost-effectiveness of the
CMS versus standard care after adjusting the baseline incidence of
caries to that of the Australian population. Over the 2-year period,
the discounted change in DMFT generated in the model was 2.64
in the CMS group and 2.92 in the standard care group (Table 8).
This increased to 3.65 in the CMS group and 4.12 in the standard
care group over the 3-year period. Over the 2-year period, the
discounted cost per patient was estimated to be $836.83 in the
CMS group and $476.45 in the standard care group. Thus, over
the 2-year period, the additional cost per DMFT avoided is
Table 5 Six-monthly transition probability stratiﬁed by tooth ID number
16 17 26 27 36 37 46 47
Probability of repeat ﬁlling 0.013147 0.009632 0.013002 0.011034 0.014103 0.009117 0.013248 0.008902
Probability of root canal 0.006943 0.003061 0.008066 0.003717 0.006601 0.004929 0.006201 0.004893
Probability of crown 0.002688 0.002949 0.003886 0.001624 0.003751 0.002457 0.004600 0.002785
Probability of extraction from repeat ﬁlling 0.000344 0.000429 0.000389 0.000420 0.000323 0.000309 0.000250 0.000333
Probability of extraction from root canal 0.002045 0.005065 0.003911 0.001991 0.000971 0.001089 0.017509 0.003816
Probability of extraction from crown 0.000311 0.000811 0.009022 0.002532 0.000508 0.001328 0.000433 0.000483
Probability of bridge 0.000169 0.0000154 0.0001159 0.0000240 0.0003660 0.0000459 0.0001684 0.0000878
Probability of implant 0.000058 0.000013 0.000102 0.000013 0.000107 0.000040 0.000103 0.000031
Australian Dental Association codes used to represent treatment: Filling/repeat ﬁlling: 511, 512, 513, 514, 515, 521, 522, 523, 524, 525, 531, 532, 533, 534, 535, 551, 552, 553, 554, 555. Root Canal:
415, 416, 417, 418. Crown: 613, 615, 618. Bridge: 642, 643. Extraction: 311, 314, 322. Implant: 661.
Table 6 Per visit cost of monitoring caries activity (in 2007 Australian Dollars)
Number
per visit
ADA
code
Average
MBF charge
Total cost
per visit
Total cost per visit for patients in the CMS arm
Diet assessment 1 131 $16.61 $16.61
Plaque assessment 1 141 $21.54 $21.54
Bitewing radiographic survey 2 022 $32.66 $65.32
Caries risk assessment 1 047 $25.85 $25.85
Oral hygiene coaching 1 111 $43.72 $43.72
Professional ﬂuoride application 1 121 $25.82 $25.82
Home ﬂuoride application 1 122 $34.63 $34.63
Periodic oral examination 1 012 $41.54 $41.54
$275.03
Total cost per visit for patients in the standard care arm
Plaque assessment 1 141 $21.54 $21.54
Bitewing radiographic survey 1.2* 022 $32.66 $39.59
Professional ﬂuoride application 1 121 $25.82 $25.82
Periodic oral examination 1 012 $41.54 $41.54
$128.49
*Assumes one double bitewing radiographic survey per year.
ADA,Australian Dental Association; CMS, Caries Management System; MBF, Medical Beneﬁts Fund.
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estimated to be $1287.07. The additional cost per DMFT avoided
decreased to $1148.91 over the 3-year period.
Over the lifetime period, the discounted change in DMFT
score generated in the model was 8.74 in the CMS group and
9.62 in the standard care group and the discounted cost per
patient was estimated to be $6479.51 in the CMS group and
$4899.86 in the standard care group. Thus, the cost-effectiveness
of the CMS decreases when the time horizon of the model is
extended to the lifetime of the patient to $1795.06.
Figure 2 illustrates the cost-effectiveness scatter plot over the
lifetime horizon, showing the individual cost and effectiveness
pairs for each of the 10,000 patients simulated in the model. The
vast majority (97.3%) of the 10,000 simulations generate an
incremental cost and effectiveness pair in the north east quad-
rant, representing a situation in which the CMS is both more
costly and more effective (at avoiding an increment in DMFT)
than the standard care group. In addition, 2.4% of the simulated
patients generate a cost and effectiveness pair in the south east
quadrant, representing a situation in which the CMS is less costly
but more effective than standard care. However, it should be
noted that 0.02% of the simulated patients fall in the north west
quadrant, representing a situation in which the CMS is more
costly but less effective than standard care.
Sensitivity Analyses
The results of one-way sensitivity analyses are shown in Table 9.
In the base-case analysis reported in Table 8, the underlying risk
of dental caries is low (assuming 0.33 new lesions per year). The
modeled rate of caries is similar to that assumed in Bader et al.
[35] for low-risk patients. The risk assessment proposed by Bader
categorizes medium risk as development of at least one new
carious lesion per year while patients categorized as high risk
would develop at least three new carious lesions per year. Assum-
ing the risk of caries is increased to represent one new carious
lesion per year, the incremental cost per DMFT avoided decreases
to $702.52 over the 3-year period and $1712.85 over the lifetime
period. If the risk of new caries is increased further to three
lesions per year, the incremental cost per DMFT avoided
decreases to $545.93 and $1585.12 over the lifetime period.
The results of the trial suggest that the incremental beneﬁt of
the CMS compared with standard dental care is maintained over
that trial period despite less than complete adherence to the
monitoring protocol. However, no data exists to validate
whether the increment beneﬁt is maintained long-term. A sensi-
tivity analysis assumes that the level of adherence and thus the
incremental effectiveness of the CMS decrease over time. In the
analysis, the incremental effectiveness of the CMS as observed in
the trial is maintained for 5 years. After that time, the incremen-
tal effectiveness is assumed to decrease linearly such that there is
no additional beneﬁt over the control arm at year 20 (i.e., after
20 years, the incidence of caries and operative interventions for
patients in the CMS will be the same as that of the standard care
group). This scenario will not affect the 2- and 3-year cost-
effectiveness results; only the lifetime results will be affected. In
this situation, the incremental cost per DMFT avoided increases
to $3275.69 over the lifetime horizon.
Axelsson [38] showed that the effectiveness of the preventive
program can be maintained indeﬁnitely if adherence to the pro-
gram’s monitoring protocol is high. The results presented by
Axelsson suggest that it is possible to fully arrest the development
of new lesions if high adherence to the program is achieved. A
sensitivity analysis assumes that the CMS is able to fully arrest
the development of new lesions and new ﬁllings for as long as the
costs associated with the CMS protocol are incurred. In this
optimistic scenario, the incremental cost-effectiveness ratio
decreases to $339.52 per DMFT avoided over the 3-year period
and $286.93 over the lifetime period.
The protocol for the CMS suggests more frequent visits than
currently performed in standard practice. However, the 2-year
and 3-year results of the clinical trial suggest that the mean
number of visits was similar between groups ([29] and Table 2).
Table 7 Unit cost of dental interventions applied as patient enter the
health state (in 2007 Australian dollars)
Intervention ADA codes included in weighted cost Unit cost*
Filling (and repeat
ﬁlling)
511, 512, 513, 514, 515, 521, 522, 523,
524, 525, 531, 532, 533, 534, 535, 551,
552, 553, 554, 555
$150.51
Root canal 415, 416, 417, 418 and 022 ¥ 2 $743.31
Crown 613, 615, 618 $1253.91
Bridge† 642, 643 and 613, 615, 618 $2203.93
Extraction 311, 314, 322 $136.96
Implant 661 and 671 and 679 and 688 $4403.82
*Weighted MBF charge based on respective utilization of individual ADA codes.
†Assumes one crown.
ADA,Australian Dental Association; MBF, Medical Beneﬁts Funds.
Table 8 Discounted cost per DMFT avoided (trial-based and modeled)
SC CMS
Incremental
(SC—CMS)
Incremental cost
per DMFT avoided
Trial-based 2-year result
Cost $615.15 $1024.92 $409.77
DMFT increment from baseline 1.9 1.2 0.7 $539.17
Trial-based 3-year result
Cost $1061.94 $1693.91 $631.96
DMFT increment from baseline 3.9 3.0 0.9 $694.47
Modeled 2-year result
Cost $476.45 $836.83 $360.38
DMFT increment from baseline 2.92 2.64 0.28 $1287.07
Modeled 3-year result
Cost $758.97 $1298.96 $539.99
DMFT increment from baseline 4.12 3.65 0.47 $1148.91
Modeled lifetime result
Cost $4899.86 $6479.51 $1579.65
DMFT increment from baseline 9.62 8.74 0.88 $1795.06
Incremental cost per DMFT avoided = incremental cost/incremental DMFT score.
CMS, Caries Management System; DMFT, decayed, missing, and ﬁlled teeth; SC, standard care.
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Thus, in the base-case, it was assumed that the mean number of
visits was similar between groups. A sensitivity analysis assumes
that the monitoring schedule in the CMS group is the same as
was reported in the protocol [28]. At baseline, 65%, 9%, and
26% of the patients in the CMS clinical trial were classiﬁed as
low, medium, and high risk [29]. In the analysis, it is assumed
that the frequency of visits for low risk, medium-risk and high-
risk patients is every 18, 6, and 3 months, respectively. In this
scenario, the incremental cost-effectiveness ratio increases to
$1468.64 per DMFT avoided over the 3-year period and
$2301.54 over the lifetime period.
When estimating the cost associated with monitoring caries
activity in the base-case analysis, it is assumed that all services are
performed by a dentist. In some circumstances, these services
could perhaps be performed by a dental hygienist or therapist.
Accordingly, the cost of monitoring caries activity would be
lower in both the CMS and control groups. However, the costs of
dental interventions such as ﬁllings remain the same as in the
base-case, as these events would most likely be performed by a
dentist. Given the relatively low cost associated with monitoring
dental caries compared with the high cost of restorative dental
treatment, it is reasonable that the cost-effectiveness of a preven-
tive dental program would be sensitive to this variable. Assuming
the hourly labor cost of a hygienist to be 0.75 times that of a
dentist (a conservative ﬁgure), the 6-monthly cost of monitoring
caries activity in the CMS and control arms decreases to $170.16
and $79.50 per patient, respectively. In this scenario, the incre-
mental cost-effectiveness ratio decreases to $802.23 per DMFT
avoided over the 3-year period and $1306.82 over the lifetime
period.
Probabilistic sensitivity analysis is required to address the
uncertainty in cost-effectiveness models. In cohort models, the
computational requirements associated with probabilistic sensi-
tivity analysis are manageable (between 1000–10,000 runs using
Monte Carlo sampling methods to allow the uncertain param-
eters to vary across their plausible ranges). However, in patient-
level simulation models, at least 10,000 patients are modeled in
order to obtain a reasonable estimate of the mean value of the
incremental cost-effectiveness ratio. Therefore, in order to gen-
erate a cost-effectiveness acceptability curve, a total of at least
10,000,000 individual simulations are required in a model such
as reported here. Given the extensive number of transitions
allowed in this model within the eight independent Markov
subgroups, the computational requirements have prevented the
viability of performing probabilistic sensitivity analysis.
Model Validity
The model was externally validated by comparing the 3-year
results generated in the model with the 3-year results observed in
the CMS clinical trial. Over the 3-year period, the discounted
incremental DMFT generated from the model was 3.65 in the
CMS arm and 4.12 in the standard care arm (Table 8). These
estimates of the DMFT increment at 3 years are similar to those
observed in the CMS clinical trial (3.26 in the CMS arm vs. 4.22
in the control arm, Table 2). The model is reasonably accurate at
predicting the DMFT increment in the standard care group (4.12
in the model vs. 4.22 observed at 3 years in the trial). However,
the model is overestimating the change in DMFT from baseline
for the CMS group at 3 years (3.65 in the model vs. 3.26
observed at 3 years in the trial). When reporting the 3-year
DMFT increment for both groups, the results presented in
Table 2 included the extraction component (represented by M) in
the analysis. However, because the observed difference in extrac-
tions between the two groups was not statistically signiﬁcant
over the 3-year period of the trial, the model assumed that the
rate of extractions is similar between the two groups. This mod-
eling assumption leads to an underestimation of the incremental
beneﬁt of the CMS when compared with standard care.
Discussion
A key consideration in any economic analysis is the perspective
from which the study is undertaken. We constructed a decision to
model the results of the CMS within private dental practice
because this is the predominant mode of providing dental ser-
vices in Australia. This should improve the generalizability of our
ﬁndings. Although the results are generalizable, it is not known
whether the ﬁndings of this research will impact dental practice
in Australia. It could be argued that many treatment decisions
undertaken within private dental practice are more likely to be
based on a patient’s willingness to pay than on cost-effectiveness,
given that a private dental practice is in effect a small business.
Further work is planned to capture some of the indirect costs
associated with dental treatment, perhaps allowing a societal
Figure 2 Incremental cost-effectiveness scatter
plot over the lifetime of the patient.DMFT,decayed,
missing, and ﬁlled teeth.
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perspective to be undertaken in future analyses. This would be
more appropriate in consideration of a societal view or for policy
driven decisions.
Units costs included in this analysis are based on average
charge data for the services performed. Thus, the unit cost is the
charge by the dental practitioner for the service, part or all of
which may be reimbursed directly to the dental practitioner by
the health insurer (MBF). The remainder will be borne by the
patient as an out-of-pocket expense. The patient population who
chooses private health insurance for auxiliary services is a self-
selecting group, usually with higher income, who are more likely
to attend dental practitioners in more afﬂuent areas. Therefore,
the potential exists for the MBF reimbursement to be higher than
the fee charged by dental practitioners in less afﬂuent areas or to
those patients without health insurance. This may affect the
generalizability (external validity) of these results.
This research provides one of the few modeled economic
analyses of preventive dental programs that both adjusts the
baseline incidence of dental caries to the population being con-
sidered, and extrapolates the costs and outcomes beyond the
duration of the clinical trial on which the efﬁcacy results are
based. Economic analyses of dental interventions, whether pre-
vention or treatment, are necessary to inform decisions that will
maximize the community’s oral health within the constraints of
the resources available. Given the growing number of economic
analyses of preventive dental programs, it is hoped that the
implications from such research will have an impact on public
policy and the support and implementation of evidence-based
dentistry.
It is evident, from Table 8, that the CMS is more cost-effective
when the analysis is based on both the baseline incidence of
dental caries and incremental efﬁcacy observed in the clinical
trial. The program becomes less cost-effective when the baseline
incidence of caries is adjusted to be equivalent to that of the
Australian population. This is emphasized in Figure 2, in which
0.02% of the simulated patients fall in the northwest quadrant,
representing a situation in which the CMS is more costly but less
effective than standard care. Given that the baseline risk of dental
caries is, on average, low in the Australian population (most
likely because of ﬂuoridation of water supply), it is understand-
able that the CMS appears less cost-effective in the broader
Australian population which has a lower baseline risk of dental
caries. Therefore, it is likely that the CMS will be more cost-
effective in patients with a higher baseline risk of dental caries.
The premise of the CMS is that regular monitoring of caries
activity reduces the incidence of carious lesions and results in
fewer operative interventions. The per protocol schedule of
monitoring caries suggested in Evans et al. [28] implies that more
frequent visits would be observed in the CMS group than the
standard care group. However, at both 2 and 3-years, the fre-
quency of visits was comparable between the two groups in the
clinical trial; thus, adherence to the monitoring protocol was less
than optimal. The frequency of visits in actual clinical practice in
Australia has not been observed, and thus the cost-effectiveness
reported in this article is only applicable to a situation in which
the frequency of visits is similar to those observed in the control
arm of the CMS clinical trial.
The 2- and 3-year results of the trial suggest that the incre-
mental beneﬁt of the CMS compared with standard dental care is
ongoing despite less than complete adherence to the monitoring
protocol. However, the long-term duration of this incremental
beneﬁt is not known. This analysis assumes that the incremental
beneﬁt observed in the trial will continue for as long as adherence
to the monitoring protocol is observed. If, in clinical practice,
adherence to the monitoring protocol decreases over time, theTa
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model will overestimate the long-term cost-effectiveness of the
CMS compared with standard dental care, although the 2 and
3-year cost-effectiveness ratios will not be affected. Only longer-
term follow-up will determine the validity of this assumption.
The main limitation of this research is that only speciﬁc
transitions are allowed in the model; whereas, in reality, patients
can move from one health state to any other health state.
However, given the extensive data requirements needed to popu-
late a model that allows all possible transitions, the authors have
limited the model to the key transitions that are most likely to be
affected by the implementation of the CMS.
Each of the eight molars was modeled independently as a
semi-Markov process. However, there is likely to be high corre-
lation between the eight models given that it is not likely that one
tooth will have dentine decay and the other seven will have “no
disease.” Moreover, the beneﬁts of the CMS are likely to affect all
teeth equally. Therefore, a simpler modeling approach would be
to assume perfect correlation between the eight molars and
reduce the model to one Markov process that models the costs
and outcomes for all eight molars. However, published evidence
(conﬁrmed by MBF data in Table 5) suggests that lower molars
are more susceptible to decay than upper molars, and patients are
more effective at brushing one side of their mouth [41,42]. Thus,
the authors thought it would be appropriate to model each of the
eight molars independently to reﬂect this concept, even though
this additional complexity inhibits the ability to perform proba-
bilistic sensitivity analysis without using a Gaussian process.
The other key limitation of the analysis relates to the use of
the composite outcome (DMFT) as the measure of effectiveness.
The DMFT is a standard composite measure when assessing
dental interventions. However, one limitation of this composite
measure is that each individual event is valued equally (i.e., the
development of a one-surface lesion has the same impact on the
total DMFT score as a missing tooth). The authors acknowledge
that an alternative approach would be to use the more sensitive
DMFS score in which a missing tooth counts as an increase of 5
points (compared with, for example, dentine decay which might
count as an increase of 2 points in the DMFS score). However, all
data relating to costs and transition probabilities are at the tooth
level rather than the surface level.
There are no comparable analyses with which to compare our
cost-effectiveness results as previous work has concentrated on
child populations within the school or public care setting. The
analysis most similar to that reported here is that of Crowley
et al. [11] which assessed cost per DMFS. However, the study by
Crowley et al. assessed the cost-effectiveness of a school-based
prevention program in nonﬂuoridated areas of Australia, and did
not include all costs associated with monitoring dental caries in
private practice. It is likely that patients in nonﬂuoridated areas
have a higher risk of developing dental caries, thus rendering any
economic evaluation performed on that population more cost-
effective than an analysis performed on the entire Australian
population. Two other economic analyses [20,21] report cost-
effectiveness in terms of incremental cost per cavity-free month.
Meaningful comparisons between published economic analyses
of dental interventions are difﬁcult, suggesting that dentistry is
undertaking a range of interventions without considering the
cost-effectiveness of these interventions. However, it is possible to
perform a comparison of the clinical beneﬁts to the different
dental programs. In the study by Morgan et al. [17], the 3-year
DMFS increment was 2.35 in the control group and 1.12 in the
intervention group (Table 3 [17]), resulting in a difference in
DMFS increment of 1.23. In comparison, the 2-year DMFS
group increments in this study were 5.4 in the standard care
group and 3.2 in the CMS group, resulting in differential DMFS
of 2.3 in favor of the CMS [29]. Note that our incremental group
scores are higher, as we treated repeat ﬁllings as incremental to
the DMFT score.
Whether or not the incremental cost-effectiveness ratios pro-
duced are acceptable or not is beyond the scope of this work.
However, unlike economic analyses of health-care interventions
which are guided by informal cost per quality-adjusted life year
(QALY) thresholds representing acceptable cost-effectiveness
(approximately £30,000 and $50,000 per QALY gained in the
UK and Australia, respectively), no such thresholds exist in the
assessment of dental programs or treatments. The authors
acknowledge that it is difﬁcult to compare the relative value for
money of dental interventions (which are assessed in terms of
cost per DMFT avoided) with other health-care interventions
that use the standard cost per QALY measure. Such an issue will
most likely only be addressed via a willingness-to-pay study to
determine the utility associated with fewer dental caries and
fewer resulting dental interventions. However, Anderson [43]
estimated that the lifetime economic impact of a probably avoid-
able ﬁlling was AUD$3300 in 2008 (converted from USD$1800
in 1997). If we accept such a threshold, it appears from our
analysis that the CMS is marginally cost-effective for low risk
patients and probably cost-effective for patients who present on
average with greater than one new lesion per year.
Conclusions
The cost effectiveness of the CMS is highly dependant on baseline
risk of caries (and the projected event rate as a result). When
compared with standard dental practice in Australia, the CMS is
most cost-effective in patients who have a high underlying inci-
dence of developing dental caries. The CMS is unlikely to be
cost-effective in patients with a low risk of developing dental
caries unless the costs associated with the program can be con-
strained (for example, by assuming that the monitoring of caries
activity is performed by a dental hygienist rather than a dentist).
The model appears to be reasonably accurate at predicting
outcomes (i.e., the incremental DMFT at 3 years generated in the
model is similar to that observed in the trial). Given that adher-
ence to the protocol was less than optimal in the CMS clinical
trial, the CMS was not completely effective at preventing any
increment in DMFT score. However, any actions to improve
adherence to the monitoring protocol would increase the incre-
mental beneﬁt of the CMS and thus the render the program more
cost-effective.
Acknowledgments
This research has received funding from the Oral Health Foun-
dation, NHMRC (project grant 402466), The Dental Board of
NSW, and the Australian Dental Research Foundation. The
support of the Australian Dental Association (NSW), Colgate,
Australian Healthcare Management, GC (Australia), and MBF
(Australia) is gratefully acknowledged.
Source of ﬁnancial support: This research has received funding from the
Oral Health Foundation, NHMRC (project grant 402466), The Dental
Board of NSW, and the Australian Dental Research Foundation.
References
1 Rindal DB, Rush WA, Boyle RG. Clinical inertia in dentistry: a
review of the phenomenon. J Contemp Dent Pract 2008;1:113–
21.
The Caries Management System 759
2 Bader J, Shugars D. The evidence supporting alternative manage-
ment strategies for early occlusal caries and suspected occlusal
dentinal caries. J Evid Based Dent Pract 2006;1:91–100.
3 Ismail AI, Bader JD. Evidence-based dentistry in clinical practice.
J Am Dent Assoc 2004;135:78–83.
4 Tan PL, Evans RW, Morgan MV. Caries, bitewings, and treat-
ment decisions. Aust Dent J 2002;47:138–41.
5 Grondahl HG, Andersson B, Tortensson T. Caries increment and
progression in teenagers when using a prevention-rather than
restoration-oriented treatment strategy. Swed Dent J 1984;8:237–
42.
6 Brennan DS, Spencer AJ. Factors inﬂuencing choice of dental
treatment by private general practitioners. Int J Behav Med
2002;9:94–110.
7 Fejerskov O. Concepts of dental caries and the consequences for
understanding the disease. Community Dent Oral Epidemiol
1997;25:5–12.
8 Arrow P. Cost minimisation analysis of two occlusal caries pre-
ventive programmes. Community Dent Oral Epidemiol 2000;17:
85–91.
9 Bhuridej P, Kuthy RA, Flach SD, et al. Four-year cost-utility
analyses of sealed and non-sealed ﬁrst permanent molars in Iowa
Medicaid-enrolled children. J Public Health Dent 2007;67:191–8.
10 Birch S. The relative cost effectiveness of water ﬂuoridation across
communities: analysis of variations according to underlying caries
levels. Community Dent Health 1990;7:3–10.
11 Crowley SJ, Campain AC, Morgan MV. An economic evaluation
of a publicly funded dental prevention programme in regional and
rural Victoria: an extrapolated analysis. Community Dent Health
2000;17:145–51.
12 Davies GM, Worthington HV, Ellwood RP, et al. An assessment
of the cost effectiveness of a postal toothpaste programme to
prevent caries among ﬁve-year-old children in the North West of
England. Community Dent Health 2003;20:207–10.
13 Donaldson C, Forbes JF, Smalls M, et al. Preventive dentistry in a
health centre: effectiveness and cost. Soc Sci Med 1986;23:861–8.
14 Kelly PG, Smales RJ. Long-term cost-effectiveness of single indi-
rect restorations in selected dental practices. Br Dent J
2004;196:639–943.
15 Manau C, Cuenca E, Martinez-Carretero J, Salleras L. Economic
evaluation of community programs for the prevention of dental
caries in Catalonia, Spain. Community Dent Oral Epidemiol
1987;15:297–300.
16 Marino R, Morgan M, Weitz A, Villa A. The cost-effectiveness of
adding ﬂuorides to milk-products distributed by the National
Food Supplement Programme (PNAC) in rural areas of Chile.
Community Dent Health 2007;24:75–81.
17 Morgan MV, Crowley SJ, Wright C. Economic evaluation of a pit
and ﬁssure dental sealant and ﬂuoride mouthrinsing program in
two non-ﬂuoridated regions of Victoria, Australia. J Public
Health Dent 1998;58:19–27.
18 Morgan MV, Campain AC, Crowley SJ, Wright FA. An evalua-
tion of a primary preventive dental programme in non-ﬂuoridated
areas of Victoria, Australia. Aust Dent J 1997;42:381–8.
19 Oscarson N, Kallestal C, Fjelddahl A, Lindholm L. Cost-
effectiveness of different caries preventive measures in a high-risk
population of Swedish adolescents. Community Dent Oral Epi-
demiol 2003;31:169–78.
20 Quinonez RB, Downs SM, Shugars D, et al. Assessing cost-
effectiveness of sealant placement in children. J Public Health
Dent 2005;65:82–9.
21 Quinonez RB, Stearns SC, Talekar BS, et al. Simulating cost-
effectiveness of ﬂuoride varnish during well-child visits for
Medicaid-enrolled children. Arch Pediatr Adolesc Med 2006;
160:164–70.
22 Ramos-Gomez FJ, Shepard DS. Cost-effectiveness model for pre-
vention of early childhood caries. J Calif Dent Assoc 1999;27:
539–44.
23 Splieth CH, Fleba S. Modelling lifelong costs of caries with and
without ﬂuoride use. Eur J Oral Sci 2008;116:164–9.
24 Widenheim J, Birkhed D. Caries-preventive effect on primary and
permanent teeth and cost-effectiveness of an NaF tablet preschool
program. Community Dent Oral Epidemiol 1991;19:88–92.
25 Australian Institute of Health and Welfare. Australia’s Dental
Generations. AIHW Cat No. DEN 165. Canberra: AIHW, 2007.
26 Burt BA, Eklund SA. Dentistry, Dental Practice, and the Commu-
nity (5th ed.). Philadelphia: WB Saunders Company, 1999.
27 Mejare I, Kallestal C, Stenlund H, Johansson H. Caries develop-
ment from 11 to 22 years of age: a prospective radiographic
study. Caries Res 1998;32:10–16.
28 Evans RW, Pakdaman A, Dennison PJ, Howe ELC. The caries
management system—an evidence-based preventive strategy for
dental practitioners. Application for adults. Aust Dent J 2008;
53:83–92.
29 Curtis BH, Evans RW, Sbaraini A, Schwarz E. The Monitor
Practice Program: is non-invasive management of dental caries in
private practice effective? Aust Dent J 2008;53:306–13.
30 Curtis BH, Evans RW, Sbaraini A, Schwarz E. Recruitment and
standardization of a group of Australian dentists for a multiprac-
tice study on dental caries prevention. Aust Dent J 2007;52:106–
11.
31 Briggs A, Sculpher M, Claxton K. Decision Modelling for
Health Economic Evaluation. Oxford: Oxford University Press,
2006.
32 Australian Bureau of Statistics Website. Population by age and
sex. Available from: http://www.abs.gov.au/ausstats/abs@.nsf/mf/
3201.0 [Accessed November 19, 2009].
33 AIHW (Australian Institute of Health and Welfare). Australia’s
dental generations, The National Survey of Adult Oral Health
2004–06. 2007.
34 Arrow P. Incidence and progression of approximal carious lesions
among school children in Western Australia. Aust Dent J
2007;52:216–26.
35 Bader JD, Perrin NA, Maupomé G, et al. Validation of a simple
approach to caries risk assessment. J Public Health Dent
2005;65:76–81.
36 AIHW (Australian Institute of Health and Welfare). Dental Sta-
tistics and Research Unit, Oral Health of Adult Public Dental
Patients, DSUR Research Report no 36. 2008.
37 Australian Bureau of Statistics Website. Life tables by age and sex.
Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/
Lookup/3302.0.55.001Main+Features12005–2007 [Accessed
November 19, 2009].
38 Axelsson P, Nystro¯m B, Lindhe J. The long-term effect of a plaque
control program on tooth mortality, caries, and periodontal
disease in adults. Results after 30 years of maintenance. J Clin
Periodontol 2004;31:749–57.
39 Evans RW, Hsiau ACY, Dennison PJ, Jalaludin B. Water ﬂuori-
dation in the Blue Mountains reduces risk of tooth decay. Aust
Dent J 2009;54:368–73.
40 Simonsen RJ. Retention and effectiveness of dental sealants after
15 years. J Am Dent Assoc 1991;22:34–42.
41 Hujoel PP, Lamont RJ, DeRouen TA, et al. Within-subject
coronal caries distribution patterns: an evaluation of randomness
with respect to the midline. J Dent Res 1994;73:1575–80.
42 Burnside G, Pine CM, Williamson PR. The application of multi-
level modeling to dental carries data. Stat Med 2007;26:4139–
49.
43 Anderson MH. Current concepts of dental caries and its preven-
tion. Oper Dent Suppl 2001;6:11–18.
760 Warren et al.
